New CDMO Amatsi-Avogadro formed

- Last updated on GMT

Related tags: Management

Amatsi and Avogadro have announced plans to team up and create what they claim will be the leading CDMO in France.

The new entity, named Amatsi Avogadro, will provide a range of development and analytical services as well as manufacturing, packaging and distribution services for clinical trials.

The firms generated combined turnover of €20m ($27.7m) in fiscal 2011 and together employ 175 staff at sites in Montpellier and Toulouse in France and Cambridge in the US.

Amatsi president Jean-Pascal Conduzorgues said teaming with Avogadro will provide “a larger range of facilities to our clients, increased development capabilities as well as a stronger quality assurance framework​.”

Related news

Show more

Related products

show more

A Winning End-to-End Solution for Oncology Studies

A Winning End-to-End Solution for Oncology Studies

Clinical Ink | 22-Feb-2021 | Technical / White Paper

Oncology clinical trials present a unique set of challenges for patients, study sites, and study sponsors. Using electronic patient reported outcomes (ePRO)...

Related suppliers

Follow us


View more